AHNS 2010 ANNUAL MEETING DURING COSM


DOWNLOAD THE AHNS 2010 ANNUAL MEETING FINAL PROGRAM

AHNS ACCREDITATION
The American Head & Neck Society (AHNS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor Continuing Medical Education for physicians.  The AHNS designates this activity for a maximum of 14.25 AMA PRA Category 1 Credit(s)TM.  Physicians should only claim credit commensurate with the extent of their participation in the activity.

 

MEETING OBJECTIVES
The conference is designed to facilitate discussion regarding the approaches used in the diagnosis, treatment, and rehabilitation of head and neck neoplasms throughout the world.  Participants should accomplish the following at the conclusion of this event:

  • Understand the role of surgery, radiation therapy, chemoradiation, and combined modality therapy in the treatment of head and neck cancer as defined by results from randomized control trials 
  • Understand the clinical uses of new novel molecular agents in the management of head and neck cancer
  • Understand the Role of surgery in the management of thyroid "laboratory" cancer
  • Understand the impact of treatment on functional outcome of head and neck cancer patients.
  • Understand novel approaches to head and neck reconstruction

SCHEDULE-AT-A-GLANCE

*Program is subject to change

WEDNESDAY, APRIL 28TH, 2010

8:00 AM - 8:15 AM WELCOME AND INTRODUCTION OF GUESTS OF HONOR
8:15 AM - 9:00 AM PLENARY SESSION #1: Clinical
9:00 AM - 9:45 AM

JOHN J. CONLEY LECTURE

Robert L. Comis, MD, Professor of Medicine and Director, Drexel University Clinical Trials Research Center, Philadelphia
9:45 AM – 10:00 AM CLINICAL POSTER DISCUSSION
10:00 AM - 10:20 AM Morning Break
10:20 AM - 11:15 AM SCIENTIFIC SESSION #1
11:00 AM - 12:00 PM

PANEL: OPTIMAL ADJUVANT TREATMENT FOR HIGH-RISK ORAL CANCER
Panel Moderator: Bhuvanesh Singh, MD, PhD

Panelists: Arlene A. Forastiere, MD, John A. Ridge, MD, PhD, Andy Trotti, MD and David G. Pfister, MD

12:00 PM - 1:00 PM

Lunch on Own OR
AHNS BUSINESS MEETING FOR MEMBERS

1:00 PM - 2:00 PM SCIENTIFIC SESSION #2
2:00 PM - 3:00 PM

JATIN P. SHAH SYMPOSIUM ON CLINICALCONTROVERSIES IN HEAD AND NECK SURGERY: UPDATE OF CLINICAL TRIALS IN HEAD & NECK ONCOLOGY

Panel Moderator: Gregory T. Wolf, MD

Update of RTOG 91-11                    Arlene A. Forastiere, MD and
Talk Title TBD                                        Jan B. Vermorken, MD, PhD
The VA Larynx Trial - Revisited           Gregory T. Wolf, MD

This session will provide expert opinion and interpretation of recent clinical trials in view of emerging biomarker data.

At the conclusion of this session, participants will be able to:

  • Discuss the relevant advances in treatment incorporating chemotherapy and radiation.
  • Better understand the selection of patients for chemoradiation.
3:00 PM - 3:20 PM Afternoon Break
3:20 PM - 3:55 PM SCIENTIFIC SESSION #3 - RECONSTRUCTION
3:55 PM - 4:30 PM PANEL: NEW HORIZONS IN HEAD AND NECK RECONSTRUCTION  
Panel Moderator: Joseph J. Disa, MD Panelists: Eben L. Rosenthal, MD, Mark K. Wax, MD, and TBD
4:30 PM – 5:30 PM SCIENTIFIC SESSION #4

THURSDAY, APRIL 29TH, 2010

8:00 AM - 8:45 AM PLENARY SESSION #2: BASIC SCIENCE
8:45 AM - 9:00 AM BASIC SCIENCE POSTER DISCUSSION
9:00 AM – 9:45 AM

HAYES MARTIN LECTURE

Adel El-Naggar, MD, PhD, Professor of Pathology and Head and Neck Surgery, The University of Texas M.D. Anderson Cancer Center, Texas; Editor-in-Chief, Head and Neck Oncology
9:45 AM - 10:00 AM AHNS AWARDS CEREMONY
10:00 AM - 10:20 AM Morning Break with Exhibitors
10:20 AM - 10:25 AM

INTRODUCTION OF THE AHNS PRESIDENT
Introduction by David W. Eisele, MD, AHNS President-Elect

10:25 AM - 11:00 AM

AHNS PRESIDENTIAL ADDRESS AND PRESIDENTIAL CITATIONS
"We Show Pictures, They Show Curves"

John A. Ridge, MD, PhD, Chief of Head & Neck Surgery, Fox Chase Cancer Center, Philadelphia, PA.

11:00 AM - 12:00 PM SCIENTIFIC SESSION #5
12:00 PM - 1:00 PM Lunch with Exhibitors
1:00 PM - 2:00 PM SCIENTIFIC SESSION #6
2:00 PM - 3:10 PM

ROLE OF SURGERY IN LABORATORY THYROID CANCER – SUPPORTED BY CLINICAL DATA?
Panel Moderator: Bryan McIver, MBChB, PhD

Panelists: Quan-Yang Duh, MD, Christopher R. McHenry, MD, Lisa A. Orloff, MD and Ashok P. Shaha, MD
3:10 PM - 3:30 PM Afternoon Break with Exhibitors
3:30 PM - 4:00 PM

NCCN GUIDELINES DISCUSSION
Panel Moderator: David G. Pfister, MD

Panelists: David W. Eisele, MD, William M. Lydiatt, MD, Ellie Maghami, MD and Bevan Yueh, MD

4:00 PM - 5:00 PM SCIENTIFIC SESSION #7
5:00 PM Meeting Adjourns
5:00 PM – 5:45 PM FELLOWSHIP INFORMATION SESSION
5:30 PM – 7:00 PM PRESIDENT’S POSTER DISCUSSION SESSION
7:15 PM – 8:30 PM AHNS PRESIDENT’S RECEPTION